Novo Nordisk’s Wegovy is the second drug approved in MASHnews2025-08-18T10:50:09+00:00August 18th, 2025|Endpoints News|
Kennedy rejects reports of 2028 run, defends top aidenews2025-08-15T19:15:37+00:00August 15th, 2025|Endpoints News|
Pfizer’s sickle cell drug candidate fails Phase 3 trialnews2025-08-15T18:11:26+00:00August 15th, 2025|Endpoints News|
Precigen’s rare disease therapy gets full approval from the FDAnews2025-08-15T15:31:43+00:00August 15th, 2025|Endpoints News|
Which large pharma might make the next move in the VEGF bispecific race?news2025-08-15T11:00:04+00:00August 15th, 2025|Endpoints News|
Pharma’s IRA fight persists as it looks to Supreme Court, lobbies for changesnews2025-08-14T18:55:18+00:00August 14th, 2025|Endpoints News|
Lilly plans to raise prices in Europe in response to Trump’s ‘most favored nation’ pushnews2025-08-14T18:44:46+00:00August 14th, 2025|Endpoints News|
While decrying mRNA for Covid, Kennedy says he supports mRNA in oncologynews2025-08-14T17:45:26+00:00August 14th, 2025|Endpoints News|
NIH backs away from mRNA research, claiming lack of public trustnews2025-08-13T19:32:31+00:00August 13th, 2025|Endpoints News|
CytomX discloses patient death in study of ADC in colorectal cancernews2025-08-13T18:44:04+00:00August 13th, 2025|Endpoints News|
